| Value | ₹1,754 Cr |
|---|
NSE filing, NSE: VSSL. Summary written from the filing by ALFA Finder's alert engine.
Vardhman Special Steels Ltd: key numbers
- Share price
- ₹328.55
- Market cap
- ₹3,180 Cr
- Revenue (annual)
- ₹1,754 Cr
- Net profit (annual)
- ₹122.0 Cr
- P/E (TTM)
- 19.7×Sector 16.7×
- Promoter holding
- 51.18%+0.12% QoQ
- FII holding
- 0.58%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vardhman Special Steels Ltd
All →Vardhman Special Steels Earnings Call Transcript: Key Takeaways
Strong quarterly performance driven by robust demand and operational efficiencies, though management warns current high EBITDA levels are unsustainable.
Vardhman Special Steels Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹600.05 Cr (+38.8% YoY), PAT ₹52.49 Cr (+51.9%), EBITDA ₹83.86 Cr; H1 PAT +72%. Strategy: forging line (₹475 Cr) and ~₹2,600 Cr capex.
Vardhman Special Steels Results Update
Vardhman Special Steels posted H1 FY27 revenue of ₹1,086.06 Crore and PAT of ₹93.68 Crore. Q2 profit rose 51.88% year on year.
Vardhman Special Steels Management Change
Vardhman Special Steels appointed Mr. Iwao Shimamoto as Non-Executive Non-Independent Director effective 27 October 2026. The board move follows the May 2025 Share Subscription Agreement with Aichi Steel Corporation.
Vardhman Special Steels Q2 FY27 Results: Net Profit ₹52.5 Cr, Up 51.7% YoY
Vardhman Special Steels Ltd reported revenue from operations of ₹600.1 Cr (+38.8% YoY) and net profit of ₹52.5 Cr (+51.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹52.5 Cr · +51.7% YoY
Vardhman Special Steels Board Meeting Date
Vardhman Special Steels Limited scheduled a board meeting on October 27, 2026. The board will consider and approve un-audited financial results for the quarter ended September 30, 2026.
Other results update announcements
All →Aatmaj Healthcare Results Update
Aatmaj Healthcare reported H1 FY27 revenue of Rs. 16.96 crore and EBITDA of Rs. 2.04 crore. The company targets 80% revenue growth for FY27.
RPG Life Sciences Results Update
RPG Life Sciences reported Q2 FY27 revenue of ₹211.6 crore, growing 16.5%, and adjusted EBITDA of ₹50.1 crore. The API business integration continues to progress.
Praruh Technologies Results Update
Praruh Technologies reported strong H1 FY27 growth, with revenue rising 378% YoY to ₹84.06 Crore and PAT increasing 733% to ₹8.18 Crore.
CARE Ratings Results Update
CARE Ratings reported strong Q2 and H1 FY27 operating income and profit growth. The board also declared an interim dividend of Rs 10 per share.
EPACK Durables Results Update
EPACK Durable reported record first-half revenue and strong Q2 FY27 growth. The board also approved exiting its EPAVO joint venture stake.
3i Infotech Results Update
3i Infotech reported Q2FY27 revenue of Rs.182.0 crore, up 4.1% year-on-year. Quarterly PAT stood at Rs.6.7 crore and 25 new client wins were added.